BioSpace News Archive

Boehringer Ingelheim today announced that the first patient has enrolled in a new clinical study to observe whether COVID-19 patients with respiratory failure are more susceptible to developing progressive Interstitial Lung Disease (ILD), or scarring of the lungs.

ClearB Therapeutics, Inc., announced today that its abstract titled “Impact of various expression systems on efficacy of HBsAg therapeutic vaccines to achieve clearance in a mouse model of chronic hepatitis B” was accepted for poster presentation at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® 2021

Optime Care, a nationally recognized pharmacy, distribution and patient management organization maximizing therapeutic opportunities for the treatment of orphan and rare disorders, is pleased to recognize November as National Family Caregivers Month and points to the benefits of Optime Care’s patient-first approach for supporting family caregivers and patients through counseling, guidance and education based upon patient and caregiver needs

Eisai Co., Ltd. announced that the Dominantly Inherited Alzheimer Network Trials Unit, led by Washington University School of Medicine in St. Louis, has an agreement with the U.S. Food and Drug Administration and the European Medicines Agency to amend the clinical study design to include a background anti-amyloid agent.

BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that it is installing a PURE EP™ System for an evaluation at the Beth Israel Deaconess Medical Center (BIDMC) in Boston, MA.

Linkam Scientific is excited to be exhibiting at ArabLab for the first time, and for it’s first in-person tradeshow in 2021, amid a period of global expansion.

First Patient Dosed in Study Evaluating Mitazalimab in Combination with Cancer Vaccine for Patients with Pancreatic Cancer

Nordic Nanovector ASA (OSE: NANO) announces the appointment of Pierre Dodion MD as Chief Medical Officer (CMO)

New England Biolabs (NEB®) announced today that they have released a kit for the generation of in vitro transcribed synthetic mRNA capped using the TriLink Biotechnologies, part of Maravai LifeSciences (NASDAQ: MRVI), CleanCap Reagent AG.

Enzychem Lifesciences (KOSDAQ: 183490), a late-stage biotechnology company, announced today that the Company has filed for Breakthrough Therapy designation (BTD) with the U.S. Food and Drug Administration (FDA) for the use of its lead investigational candidate in chemoradiation-induced oral mucositis (CRIOM).